PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung Cancer

NCT01281787 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

320

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer
Atrial Fibrillation

Interventions

DRUG: Metoprolol
DRUG: Losartan

Sponsor

European Institute of Oncology